Blog
RSS FeedPosted by Michael Wonder on 02 Nov 2021
Pricing vaccines and drugs in Europe: worth differentiating?
1 November 2021 - The COVID-19 pandemic has recently brought to the forefront the vital importance of vaccines, of which Europe ...
Posted by Michael Wonder on 07 Apr 2021
UK rolls out Moderna's COVID vaccine
7 April 2021 - The UK rollout of Moderna's coronavirus vaccine has begun today in Wales, following its approval back ...
Posted by Michael Wonder on 16 Jan 2021
NICE’s approach to measuring value
5 January 2021 - Appleby asks whether COVID-19 vaccines would be considered cost effective using the NICE approach to measuring ...
Posted by Michael Wonder on 08 Dec 2020
Britain begins vaccine rollout, first person vaccinated
8 December 2020 - A 90-year-old British grandmother has become the first person in the world to receive the Pfizer ...
Posted by Michael Wonder on 02 Dec 2020
Britain becomes the first country to license a fully tested COVID-19 vaccine
1 December 2020 - Inoculations with the Pfizer-BioNTech jab could start in less than a week. ...
Posted by Michael Wonder on 30 Nov 2020
UK secures another two million doses of Moderna’s COVID-19 vaccine
30 November 2020 - The UK government has secured an additional two million doses of Moderna’s COVID-19 vaccine mRNA-1273, taking ...
Posted by Michael Wonder on 29 Nov 2020
Will COVID-19 vaccines be cost effective—and does it matter?
26 November 2020 - The costs of other pandemic measures mean that covid-19 vaccines will probably turn out to be ...
Posted by Michael Wonder on 17 Nov 2020
UK strikes deal for five million doses of Moderna’s COVID-19 vaccine
17 November 2020 - The UK government has secured access to five million doses of Moderna’s COVID-19 vaccine after interim ...
Posted by Michael Wonder on 07 Sep 2020
AstraZeneca vaccine ‘most likely’ to roll out in the U.K. early next year
7 September 2020 - Rise in U.K. COVID cases is predominantly among younger people, health secretary says. ...
Posted by Michael Wonder on 04 Aug 2020
UK increases COVID-19 vaccine manufacturing capacity
4 August 2020 - The UK government has signed a new deal with biotech organisation Wockhardt to increase the manufacturing ...
Posted by Michael Wonder on 29 Jul 2020
Sanofi and GSK agree with the UK government to supply up to 60 million doses of COVID-19 vaccine
29 July 2020 - Both companies are committed to making their COVID-19 vaccine candidate affordable and available globally. ...
Posted by Michael Wonder on 20 Jul 2020
Government signs deals with BioNTech/Pfizer and Valneva for COVID vaccines
20 July 2020 - The Government has signed new deals with BioNTech/Pfizer and Valneva for access to 90 million doses ...
Posted by Michael Wonder on 05 Jul 2020
Britain nears $625 million Sanofi/GSK COVID-19 vaccine deal
5 July 2020 - Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for ...
Posted by Michael Wonder on 15 Jun 2020
The unprecedented challenge of pricing a coronavirus vaccine
12 June 2020 - The optimal pricing strategy for a new vaccine involves setting a fair and sustainable price that ...
Posted by Michael Wonder on 16 Apr 2020
Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19
16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...